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Abstract
Background: Previously, it has been demonstrated that obesity is one of the strongest
risk factors for incident chronic kidney diseases (CKDs). Currently, we examine the
association between Body mass index (BMI) and CKD in first degree relatives (FDRs)
of renal failure patients on hemodialysis.
Materials andmethods: In a cross-sectional study, 135 FDRs of end-stage renal disease
(ESRD) patients on hemodialysis were included. Serum creatinine, uric acid, calcium,
phosphate, and alkaline phosphatase were measured. Glomerular filtration rate (e-
GFR) and albumin to creatinine ratio (ACR) were estimated. The height in Cm, weight
in Kg was measured, and the BMI was calculated.
Results: Females 64% were found to have a higher frequency than males 36%. The
frequency of BMI categories was found to be 26.7% obese, 26.7% overweight, and
46.6. % normal weight. The mean BMI was (26.0 ± 6.62). The prevalence of CKDs
is 19.3% among relatives. CKDs were more frequent 42.3 % in obese, followed by
30.8 % in overweight and 26.9% in normal-weight relatives. Obese and overweight
relatives have significantly higher ACR than normal weight (P= 0.012). GFR found to be
significantly higher in obese and overweight relatives than normal weight (P = 0.000).
GFR was negatively correlated with BMI (R = - 0.430, P = 0.000).
Conclusion: Obese and overweight RF relatives had higher ACR and lower eGFR.
Therefore, obese and overweight members are at higher risk of developing CKD.
Keywords: CKDs, Family members, BMI, Obesity, ACR, eGFR.
1. Introduction
Chronic kidney disease (CKD) is a global public health problem [1], increasing rapidly
worldwide and is gaining much attention in both the developed as well as developing
countries [2]. It is found in 10% of the global population [3], and it affects 10-16% of the
adult population in China, Asia, Australia, Europe, and the United States [4]. In Sudan, as
Abu-Aisha et al. reported in their pilot study in 2009, the prevalence range was 7.7 - 11%
[5]. CKD is considered as a health issue associated with increased morbidity, mortality,
and health care costs [3, 4].
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Beside CKD, Obesity is another global pandemic problem; it is associated with various
metabolic disorders such as CKD and results in a shortened life span related to adverse
health consequences. In Sudan, the high prevalence of obesity was observed, and
it was found that it is associated with diabetes and hypertension [6]. Epidemiological
studies have demonstrated that obesity, a family history of ESRD and high body mass
index (BMI) are essential risk factors for incident CKD and increased risk of ESRD [7, 8],
and associated with an increased risk of CKD development among adult individuals in
the general population [9].
Several studies showed that; the FDRs of ESRD patients with a family history are at
risk to develop CKD [10, 11]. Furthermore, increased BMI and obesity were found to be
having direct impact on the development of CKD and ESRD [8], through a compensatory
mechanism of hyperfiltration occurs to meet the heightened metabolic demands of the
increased body weight and the increase in intraglomerular pressure which can damage
the kidney structure and raise the risk of developing CKD in long term [8]. This study
aims to find out the association between BMI and CKD among FDRS of Sudanese
hemodialysis patients.
2. Materials and Methods
In a cross-sectional study, 135 randomly selected family members (first-degree rela-
tives) of chronic end-stage renal failure on hemodialysis attending different centers in
Khartoum State were included. Ages ranged between 17-60 years old. After informed
consent, blood samples were collected, under the aseptic condition from relatives. Sub-
ject with diabetes mellitus, hypertension, cancer, thyroid dysfunction, glucocorticoids
therapy, HIV, pregnancy, and hepatitis were excluded. The selection based on clinical
history records. The demographic data were gathered using instructed questionnaire.
The height in cm and weight in Kg were estimated, then BMI was calculated. ACR
and e-GFR were measured. Elevated ACR (>30 mg/g) and/or reduced e-GFR (<60
ml/min/1.73m2) considered as CKDs.
2.1. Ethical approval
The study was approval by the local ethical committee of Al-Neelain University and
Ministry of Health. Written informed consent was obtained from all participants.
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2.2. Estimation of ACR
Brief according tomanufacturer Also, mid-stream single spot urine samplewas collected.
Albumin was measured by turbidimetry assay. Urine creatinine was estimated by Jaffe
method Cobas C-311® fully automated analyzer. Albumin-creatinine ratio was calculated
byMedical, Scy-med calculator, and expressed inmg/g. ACR>30mg/gmwas considered
as albuminuria.
2.3. Estimation of e-GFR
Estimated-GFR was calculated by MDRD and CKD-EPI equations (reduced GFR was
detected when eGFR<60 ml/min/1.73m2).
2.4. Statistical analysis
The Statistical Package for Social Sciences (SPSS), version 21.0 (SPSS Inc., Chicago,
USA) was used for data analyses. Results were presented as frequencies, percentage,
Mean ± SD and regression coefficient. The student’s t-test was used to compare mean
levels between groups. Chi-esquire was used for qualitative data. Person’s correlation
was employed to determine the association between continuous variables. P-value ≤
0.05 was considered as the statistical significance.
3. Results
In this study, 135 family members were participated. Table 1 shows the demographic
and characteristics data, table 2 shows the frequency and distribution of CKD and table
3 shows the mean levels of ACR and e-GFR according to BMI categories, while Figure
1 shows association of BMI with ACR and e-GFR. 64% were Females and 36% males.
Their mean age was (32.3 ± 14.1). The frequency of BMI categories was found to be
26.7% obese, 26.7% overweight, 39.2% normal weight and 7.4% underweight. The mean
BMI was (26.0 ± 6.62). The prevalence of CKDs is 19.3% among relatives. CKDs were
more frequent 42.3 % in obese, followed by 30.8% in overweight and 26.9% in normal
weight relatives. Obese and overweight relatives have significantly higher ACR than
normal weight (P= 0.012). GFR found to be significantly higher in obese and overweight
relatives than normal weight (P = 0.000). GFR was negatively correlated with BMI (R = -
0.430, P = 0.000).
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Table 1: Demographic and characteristic data among first degree relatives of hemodialysis patients (N =
135).
Characteristics Frequency (%) or
Mean ± SD
Variable Frequency (%) or
Mean ± SD
Gender: N (%) Age Groups: N (%)
Male 49 (36 %) ≤ 20 years 32 (23.7 %)
Female 86 (64 %) 21 - 40 Years 65 (48.1 %)
Age: (Mean ± SD) (32.3 ± 14.1) > 40 Years 38 (28.1 %)
BMI: (Mean ± SD) (26.0 ± 6.62) ACR: N (%)
BMI Classification: N (%) >30 mg/gm. 23 (17.0 %)
Normal weight 63 (46.6 %) ≤ 30 mg/gm. 112 (83.0 %)
Overweight 36 (26.7 %) GFR – MDRD: N (%)
Obese 36 (26.7 %) < 60 ml/min/1.73m2 9 (6.70 %)
> 60 ml/min/1.73m2 126 (93.3)
Table 2: Frequency of chronic kidney disease and its distribution based on BMI and age categories among
first degree relatives of hemodialysis patients (N = 135).
Characteristics Frequency (%)
Chronic kidney disease 26 (19.3 %)
BMI Categories
Normal weight 7 (26.9 %)
Overweight 8 (30.8 %)
Obese 11 (42.3 %)
Total 26 (100 %)
Age group
≤ 20 years 5 (19.2 %)
21 - 40 Years 9 (34.6 %)
> 40 Years 12 (46.2 %)
Total 26 (100 %)
Table 3: The mean levels of ACR and e-GFR based on BMI categories in total first-degree relatives.
Parameters BMI categories Mean ± SD P- value
ACR (mg /gm.) Normal weight 12.0 ± 6.60
Overweight 16.5 ± 9.80
Obese 21.6 ± 8.90
0.012
GFR - MDRD Normal weight 90.7 ± 20.2
Overweight 77.4 ± 21.6
Obese 77.7 ± 25.8
0.000
4. Discussion
Concurrent with several previous studies that showed increased prevalence of CKDs
[12], this study has demonstrated higher prevalence (19.3%) of CKDs among family
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Figure 1: A: Correlation between BMI and estimated -GFR, B: Correlation between BMI and ACR.
members of renal failure patients. Moreover, the frequency data showed that, CKDs
is more frequent in adults followed by adolescence and youngest. Meanwhile, in 135
of first-degree relatives, higher frequency of obesity was noted, followed by over-
weight and normal weight. Several previous studies have reported similar findings that,
increased BMI was independent risk factor for CKDs in general population, diabetes and
hypertension [13–16]. Indeed, obesity is known to affect hemodynamic, insulin resis-
tance, adipokines changes, low grade inflammation, oxidative stress and endothelial
dysfunction, therefore has been suggested to be a risk factor of CKDs. Previous studies
have shown that, obesity lead to intraglomerular pressure, which damage the kidneys
structure and raise the risk of developing CKD in long term [17, 18]. Whereas adiponectins
from adipocyte are postulated to be involved in the pathogenesis and progression of
CKD [19].
In contrast, few studies demonstrated an insignificant association between increased
BMI and CKD [20, 21]. This contradiction attributed to obesity paradox, which suggested
to have a protective effect against CKD progression and mortality [22].
Comparison analysis revealed that, obese and overweight relatives had significantly
higher ACR and lower e-GFR levels than normal weight, therefore, have been suggested
as potential risk factors of CKDs among family members. These findings similar from
those reported that, albumin excretion rate is increased in obese subjects, also obese
non diabetic subjects had a greater risk for microalbuminuria [23–25]. Since the obesity
increases renal plasma flow, hyperfiltration and promote renal injury, consequently
proteinuria [26–29]. On the other hand, the reduced level of e-GFR among individuals
with increased BMI, in addition some data in support of this finding that, the BMI of 30
kg/m2 or more is associated with rapid loss of kidney function in patients with eGFR of
at least 60 mL/min /1·73 m2 [30, 31].
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In the present study, the comparison analysis was further reinforced by Person’s
correlation of eGFR and BMI that, eGFR positively associated with BMI. In fact, the
association of obesity with an increased ACR-based CKD risk was previously reported
[32]. In contrast, our results differ from those demonstrated that, the BMI is independent
factor of CKD [33].
5. Conclusion
In conclusion, the prevalence of CKDs is 19.3% among relatives. Obese and overweight
relatives had higher ACR and lower eGFR. Meanwhile, BMI inversely associated with
eGFR. Therefore, obese and overweight chronic renal failure relatives are at increased
risk for developing CKDs.
6. Limitations of the Study
Limited number of relatives, the diagnosis of albuminuria based on single laboratory
measurement.
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